A contribution to the debate on the laboratory criteria that define the antiphospholipid syndrome.
Pengo
V
V
D017152:Antibodies, Antiphospholipid / Q000737:chemistry*; D016736:Antiphospholipid Syndrome / Q000175:diagnosis / Q000378:metabolism*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007074:Immunoglobulin G / Q000737:chemistry; D016682:Lupus Coagulation Inhibitor / Q000737:chemistry / Q000378:metabolism; D010743:Phospholipids / Q000737:chemistry; D011933:Reagent Kits, Diagnostic / Q000592:standards; D015203:Reproducibility of Results; D012307:Risk Factors; D012680:Sensitivity and Specificity; D012698:Serologic Tests / Q000379:methods / Q000592:standards; D013923:Thromboembolism; D053482:beta 2-Glycoprotein I / Q000097:blood
D017152:Antibodies, Antiphospholipid; D007074:Immunoglobulin G; D016682:Lupus Coagulation Inhibitor; D010743:Phospholipids; D011933:Reagent Kits, Diagnostic; D053482:beta 2-Glycoprotein I